Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.651,52
0,36%
NASDAQ
18.459,67
-0,07%
Bitcoin
65.113,62
0,40%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
24/07/202010:47UK RegulatoryEvgen Pharma PLC Share option exercise and issue of equityLSE:EVGEvgen Pharma Plc
17/07/202013:05UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
16/07/202015:52UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
19/06/202008:00UK RegulatoryEvgen Pharma PLC Notice of AGMLSE:EVGEvgen Pharma Plc
17/06/202011:42Alliance NewsAlliance NewsEvgen Pharma Says SFX-01 To Be Evaluated In Covid-19 TrialLSE:EVGEvgen Pharma Plc
17/06/202008:00UK RegulatoryEvgen Pharma PLC SFX-01 to be evaluated in COVID-19 trialLSE:EVGEvgen Pharma Plc
15/06/202011:24Alliance NewsAlliance NewsEvgen Pharma Loss Slightly Wider On Expenses And CompensationLSE:EVGEvgen Pharma Plc
15/06/202008:00UK RegulatoryEvgen Pharma PLC Final ResultsLSE:EVGEvgen Pharma Plc
08/06/202008:00RNS Non-RegulatoryEvgen Pharma PLC Paper on SFX-01 in ER positive breast cancerLSE:EVGEvgen Pharma Plc
05/06/202008:00UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
15/05/202013:30UK RegulatoryEvgen Pharma PLC Statement Re: Share Price MovementLSE:EVGEvgen Pharma Plc
30/04/202008:00UK RegulatoryEvgen Pharma PLC Directorate ChangeLSE:EVGEvgen Pharma Plc
13/02/202017:17Alliance NewsAlliance NewsEvgen Pharma, Rochester University To Advance SFX-01 For TrialLSE:EVGEvgen Pharma Plc
13/02/202008:01UK RegulatoryEvgen Pharma PLC University of Rochester CollaborationLSE:EVGEvgen Pharma Plc
06/02/202014:45Alliance NewsAlliance NewsEvgen Pharma Hails "Positive" Data From Breast Cancer Drug ResearchLSE:EVGEvgen Pharma Plc
06/02/202008:00UK RegulatoryEvgen Pharma PLC University of Manchester collaboration discoveryLSE:EVGEvgen Pharma Plc
29/01/202015:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
29/01/202015:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
17/12/201912:28Alliance NewsAlliance NewsEvgen Pharma Outlook Confident Amid Clinical Success And Trimmed LossLSE:EVGEvgen Pharma Plc
17/12/201908:01RNS Non-RegulatoryEvgen Pharma PLC Investor presentationLSE:EVGEvgen Pharma Plc
17/12/201908:00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
05/12/201916:19Alliance NewsAlliance NewsEvgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 TrialsLSE:EVGEvgen Pharma Plc
05/12/201908:00UK RegulatoryEvgen Pharma PLC MOU with The University of DundeeLSE:EVGEvgen Pharma Plc
11/11/201913:23Alliance NewsAlliance NewsUPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid DevelopmentLSE:EVGEvgen Pharma Plc
11/11/201913:11UK RegulatoryEvgen Pharma PLC SAS study clarificationLSE:EVGEvgen Pharma Plc
11/11/201910:11Alliance NewsAlliance NewsEvgen Pharma Shares Drop On "Disappointing" SFX-01 Trial ResultsLSE:EVGEvgen Pharma Plc
11/11/201908:00UK RegulatoryEvgen Pharma PLC SFX-01 results in SAS studyLSE:EVGEvgen Pharma Plc
30/09/201908:00UK RegulatoryEvgen Pharma PLC ESMO presentation of Phase II STEM clinical dataLSE:EVGEvgen Pharma Plc
23/09/201914:09Alliance NewsAlliance NewsEvgen Pharma "Delighted" With Extended Breast Cancer Treatment ResultsLSE:EVGEvgen Pharma Plc
23/09/201908:00UK RegulatoryEvgen Pharma PLC Update on extended-use phase of STEM trialLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
FBK
Finecobank
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network